Sales Growth YoY (Last 12 Months): sonomapharma.com (SNOA)

Brandmark of Sonoma Pharmaceuticals Inc. (SNOA)

This rolling 12-month YoY revenue growth chart demonstrates demand dynamics, where the 39.00 mark indicates the level of current purchasing power for Sonoma Pharmaceuticals (SNOA). Niche protection is ensured by CE and FDA certifications, as well as patents for wound-healing formulations. Stable cash flow and margins are supported by the unique Microcyn technology. However, business success depends on dermatologist approval and the cost of chemical raw materials.

Sonoma Pharmaceuticals (SNOA) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/19/2026

Sonoma Pharmaceuticals - analytical breakdowns and key metrics (SNOA)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:sonomapharma.com, SNOA
Original product of Sonoma Pharma

Professional managers utilize fundamental metrics to filter assets, assessing business expansion rates through rolling year revenue dynamics. This LTM (Last Twelve Months) trading income growth metric measures the speed of cash inflows, which is critical for Sonoma Pharmaceuticals (SNOA) due to its total dependence on the production stability of external CMOs while managing marketing independently.